SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021

We conducted a nationwide retrospective cohort study to estimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection among recipients of 4 different vaccines in South Korea. Age-adjusted breakthrough infection rate per month was highest for Janssen (42.6/100,000 popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Seonju, Choe, Young June, Kim, Jia, Kim, Yoo-Yeon, Kim, Ryu Kyung, Jang, Eun Jung, Lim, Do Sang, Byeon, Hye Ryeon, Lee, Sangwon, Park, Eonjoo, Kim, Seung-Jin, Park, Young-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888240/
https://www.ncbi.nlm.nih.gov/pubmed/35202529
http://dx.doi.org/10.3201/eid2803.212210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888240/
https://www.ncbi.nlm.nih.gov/pubmed/35202529
http://dx.doi.org/10.3201/eid2803.212210

Ejemplares similares